TCL Archive FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy October 26, 2007
TCL Archive Blueprint Group co-chairman Mark Ratain says group seeks “the perfect peer review system,” but a member’s email questions the proposal. August 13, 2004
TCL Archive Clinical Trial Pathology Improvements Recommended By Group Remaining Actions After Merit Review January 12, 1979
TCL Archive In Brief: Parkinson To Leave CTEP For Novartis; FTC To Permit Sandoz, Ciba-Geigy Merger January 10, 1997
